Skip to main navigation Skip to search Skip to main content

SECUKINUMAB PROVIDES SUSTAINED MINIMAL DISEASE ACTIVITY (MDA) AND REMISSION RELATED TO DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA): 2-YEAR RESULTS FROM A PHASE 3 STUDY

  • Laura C. Coates
  • , Peter Nash
  • , Tore Kristian Kvien
  • , Laure Gossec
  • , Philip J. Mease
  • , Lawrence Rasouliyan
  • , Luminita Pricop
  • , Corine Gaillez
  • , Josef S. Smolen

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalActa Dermato-venereologica
Volume98
StatePublished - Jan 1 2018

Disciplines

  • Dermatology
  • Medicine and Health Sciences

Cite this